Loading clinical trials...
Loading clinical trials...
A Three-Part Phase 1 Study to Evaluate the Potential Drug Interactions Between ALXN2050 and Cyclosporine, Tacrolimus, and Mycophenolate Mofetil in Healthy Adult Participants
Conditions
Interventions
ALXN2050
Cyclosporine
+2 more
Locations
1
United States
Clinical Study Site
Tempe, Arizona, United States
Start Date
January 11, 2022
Primary Completion Date
March 21, 2022
Completion Date
March 21, 2022
Last Updated
April 4, 2023
NCT07470866
NCT00104325
NCT06637865
NCT07388667
NCT07221448
NCT07118891
Lead Sponsor
Alexion Pharmaceuticals, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions